LegisTrack
Back to all bills
HR 372119th CongressIn Committee

Drug Testing for Welfare Recipients Act

Introduced: Jan 13, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

This bill, titled the Drug Testing for Welfare Recipients Act, would require drug screening and testing as a condition for receiving certain federal welfare benefits. It applies to three programs: Temporary Assistance for Needy Families (TANF) under the Social Security Act, the Supplemental Nutrition Assistance Program (SNAP), and housing assistance programs funded under the U.S. Housing Act (including public housing and Section 8 rental assistance). For adults 18 and older, states or relevant administering entities would be required to check for drug-related offenses in the prior five years and conduct drug testing or screening as a prerequisite to benefit eligibility (or continued eligibility in some cases). If an individual tests positive for a controlled substance, or fails certain screening steps, benefits would be denied or suspended for up to 12 months (or longer if treatment is not completed or further testing remains positive). States would face financial penalties if they fail to enforce the requirements, and the rule would take effect 240 days after enactment. The bill also authorizes the use of certain program funds to cover testing costs, but prohibits charging individuals or households for testing. It includes detailed definitions of terms like “controlled substance,” “drug-related offense,” and “substance abuse screening,” and adds enforcement provisions that would reduce a state’s or housing agency’s federal funding if compliance is not achieved. Sponsor and process: Introduced in the House by Rep. Rouzer on January 13, 2025. The bill would be referred to the Ways and Means Committee, and to the Agriculture and Financial Services committees as well.

Key Points

  • 1Applies to three major federal programs for adults 18+: TANF (Cash welfare), SNAP (food benefits), and housing assistance (public housing and Section 8).
  • 2Eligibility/testing framework:
  • 3- Lookback for drug-related arrests in the prior 5 years.
  • 4- If arrested, the individual must test negative for at least one designated controlled substance.
  • 5- If not arrested, the individual must undergo screening; if high risk, or if screening indicates high risk and a test is positive, testing for at least one substance is required.
  • 6Consequences for positive results or failing screening: no or suspended benefits for up to 12 months, or longer until treatment is completed and/or negative test results are achieved for the relevant substances.
  • 7Testing/screening logistics: States or administering entities control the testing/screening process, but costs cannot be charged to individuals.
  • 8Penalties for noncompliance by states/housing agencies: If a state or housing entity substantially fails to enforce the requirements, federal funding for that year can be cut by 15% for the next year.
  • 9Effective date: Provisions take effect 240 days after enactment.
  • 10Funding use for testing: Specifies that certain housing funds (and related program funds) may be used to pay for testing costs.

Impact Areas

Primary affected group/area:- Low-income adults 18+ participating in TANF, SNAP (as part of eligibility rules for households), and those receiving or applying for public housing or Section 8 rental assistance.Secondary group/area affected:- State and local agencies administering TANF, SNAP, public housing, and Section 8 programs (impacting administrative processes, budgeting, and compliance activities).Additional impacts:- Financial: Potential reductions in federal grants to states/housing authorities if noncompliance is found; costs for testing may be funded with program dollars, not charged to individuals.- Program operations: Adds new eligibility prerequisites and testing regimes; requires state discretion on which substances to test and how to conduct screening.- Legal/policy considerations: Raises concerns about privacy, due process, and potential civil rights impacts; may prompt implementation variability across states due to state-determined testing parameters.- Treatment and public health: Creates incentives for treatment participation but may also impose barriers for those who test positive or who are unable to access timely treatment.
Generated by gpt-5-nano on Oct 31, 2025